NOTCH3 and ovarian serous carcinoma: Moreover, recent large-scale genomic and epigenomic analyses of high-grade serous ovarian carcinomas by The Cancer Genome Atlas (TCGA) Network revealed altered Notch signaling in 22% of cases with alterations in Notch3 occurring in 50% of those cases [11].